OCBCO
XBI icon

Oversea-Chinese Banking Corp (OCBC)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$447K Sell
3,500
-45,151
-93% -$5.64M 0.01% 280
2025
Q4 		$5.93M Buy
48,651
+694
+1% +$79.6K 0.16% 98
2025
Q3 		$4.8M Buy
+47,957
New +$4.32M 0.12% 109

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s XBI Position: Q1 2026 in Review

Oversea-Chinese Banking Corp (OCBC) reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 93% in Q1 2026, selling an estimated $5.64M and leaving 3,500 shares worth $447K. The position accounts for 0.01% of the portfolio, ranked #280.

Oversea-Chinese Banking Corp (OCBC) first reported a position in XBI in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.93M in Q4 2025. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Oversea-Chinese Banking Corp (OCBC) held 3,500 shares of State Street SPDR S&P Biotech ETF worth $447K as of Q1 2026.
  • Oversea-Chinese Banking Corp (OCBC) sold 45,151 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $5.64M.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q1 2026, its #280 holding.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in State Street SPDR S&P Biotech ETF in Q3 2025 and has held it in 3 quarters since.
  • Oversea-Chinese Banking Corp (OCBC)'s State Street SPDR S&P Biotech ETF position peaked at $5.93M in Q4 2025.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2026, filed 28 Apr 2026.